ENDRA Life Sciences Inc. (NDRA)

USD 4.62

(0.87%)

Operating Expenses Summary of ENDRA Life Sciences Inc.

  • ENDRA Life Sciences Inc.'s latest annual operating expenses in 2023 was 10.52 Million USD , down -22.13% from previous year.
  • ENDRA Life Sciences Inc.'s latest quarterly operating expenses in 2024 Q2 was 2.18 Million USD , down -18.13% from previous quarter.
  • ENDRA Life Sciences Inc. reported a annual operating expenses of 13.15 Million USD in annual operating expenses 2022, up 14.43% from previous year.
  • ENDRA Life Sciences Inc. reported a annual operating expenses of 11.49 Million USD in annual operating expenses 2021, down -0.03% from previous year.
  • ENDRA Life Sciences Inc. reported a quarterly operating expenses of 2.72 Million USD for 2024 Q1, up 95.12% from previous quarter.
  • ENDRA Life Sciences Inc. reported a quarterly operating expenses of 10.24 Million USD for 2023 FY, down -22.13% from previous quarter.

Annual Operating Expenses Chart of ENDRA Life Sciences Inc. (2023 - 2014)

Historical Annual Operating Expenses of ENDRA Life Sciences Inc. (2023 - 2014)

Year Operating Expenses Operating Expenses Growth
2023 10.52 Million USD -22.13%
2022 13.15 Million USD 14.43%
2021 11.49 Million USD -0.03%
2020 11.5 Million USD 6.07%
2019 10.84 Million USD 24.1%
2018 8.73 Million USD 81.85%
2017 4.8 Million USD 131.96%
2016 2.07 Million USD -10.42%
2015 2.31 Million USD 26.61%
2014 1.82 Million USD 0.0%

Peer Operating Expenses Comparison of ENDRA Life Sciences Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 92.939%
Prenetics Global Limited 60.73 Million USD 82.678%
Star Equity Holdings, Inc. 16.27 Million USD 35.345%
CareDx, Inc 277.76 Million USD 96.212%
Exact Sciences Corporation 2.06 Billion USD 99.489%
Exagen Inc. 52.29 Million USD 79.881%
Inotiv, Inc. 246.9 Million USD 95.739%
Guardant Health, Inc. 901.62 Million USD 98.833%
Biodesix, Inc. 77.41 Million USD 86.411%
BioNexus Gene Lab Corp. 3.92 Million USD -168.175%
Precipio, Inc. 13.63 Million USD 22.857%
iSpecimen Inc. 16.27 Million USD 35.365%
Natera, Inc. 938.98 Million USD 98.88%
Aspira Women's Health Inc. 24.11 Million USD 56.371%
Standard BioTools Inc. 113.48 Million USD 90.73%
23andMe Holding Co. 420.73 Million USD 97.499%
Castle Biosciences, Inc. 242.78 Million USD 95.667%
Personalis, Inc. 128.14 Million USD 91.79%
Aclaris Therapeutics, Inc. 110.52 Million USD 90.481%
Applied DNA Sciences, Inc. 16.48 Million USD 36.187%
OpGen, Inc. 30.65 Million USD 65.684%
T2 Biosystems, Inc. 41.49 Million USD 74.645%
Myriad Genetics, Inc. 600.1 Million USD 98.247%
ICON Public Limited Company 755.64 Million USD 98.608%
NeoGenomics, Inc. 341.25 Million USD 96.917%
Star Equity Holdings, Inc. 16.27 Million USD 35.345%
IDEXX Laboratories, Inc. 1.09 Billion USD 99.037%
RadNet, Inc. 268.87 Million USD 96.087%
MDxHealth SA 71.25 Million USD 85.235%
Psychemedics Corporation 11.33 Million USD 7.175%
Illumina, Inc. 3.81 Billion USD 99.724%
Check-Cap Ltd. 19.28 Million USD 45.452%
Twist Bioscience Corporation 354.18 Million USD 97.03%
DarioHealth Corp. 62.17 Million USD 83.078%
Fulgent Genetics, Inc. 171.9 Million USD 93.88%
Sera Prognostics, Inc. 39.91 Million USD 73.643%
OPKO Health, Inc. 574.68 Million USD 98.169%
Medpace Holdings, Inc. 187.68 Million USD 94.394%
Neogen Corporation 405.23 Million USD 97.404%
Intelligent Bio Solutions Inc. 11.7 Million USD 10.147%
Prenetics Global Limited 60.73 Million USD 82.678%
Mainz Biomed B.V. 27.15 Million USD 61.256%
bioAffinity Technologies, Inc. 8.76 Million USD -20.033%
Trinity Biotech plc 46.49 Million USD 77.372%
Neuronetics, Inc. 82.25 Million USD 87.21%
Sotera Health Company 300.46 Million USD 96.499%
bioAffinity Technologies, Inc. 8.76 Million USD -20.033%